Unjha Formulations Reports Profit Turnaround in Q2 Despite Revenue Dip

Unjha Formulations Limited , a pharmaceutical company, has reported a significant turnaround in its financial performance for the second quarter, despite a slight decline in revenue. The company's board of directors approved the unaudited financial results for the quarter and half-year ended September 30, at a meeting held on November 10.

Q2 Performance Highlights

Particulars (in Rs. lacs)	Q2 FY2026	Q1 FY2026	Q2 FY2025	% Change (QoQ)	% Change (YoY)
Net Sales	428.53	361.41	378.19	18.57%	13.31%
Total Income	434.74	363.40	380.66	19.63%	14.21%
Total Expenditure	352.96	324.41	391.72	8.80%	-9.90%
Profit/(Loss)	81.78	38.99	-11.06	109.75%	839.42%
EPS (Basic & Diluted)	1.83	0.90	-0.25	103.33%	832.00%

Unjha Formulations has demonstrated a remarkable improvement in its profitability for the quarter ended September 30. The company reported a profit of Rs 81.78 lacs, a substantial increase from the profit of Rs 38.99 lacs in the previous quarter and a significant turnaround from the loss of Rs 11.06 lacs in the same quarter of the previous year.

Revenue Growth and Cost Management

The company's net sales for Q2 stood at Rs 428.53 lacs, showing an increase of 18.57% compared to the previous quarter and 13.31% year-on-year. This growth in revenue, coupled with effective cost management, has contributed to the improved bottom line.

Total expenditure for the quarter was Rs 352.96 lacs, an increase of 8.80% from the previous quarter but a decrease of 9.90% compared to the same period last year. This indicates that the company has been successful in controlling its costs while growing its revenue.

Half-Year Performance

For the half-year ended September 30, Unjha Formulations reported:

Net sales of Rs 789.94 lacs, up from Rs 773.40 lacs in the same period last year
Total income of Rs 798.15 lacs, compared to Rs 776.08 lacs in H1 of the previous year
A profit of Rs 120.78 lacs, more than doubling from Rs 58.82 lacs in the previous year's first half

Balance Sheet Highlights

As of September 30, the company's financial position shows:

Total assets of Rs 645.15 lacs, up from Rs 455.65 lacs at the end of the previous fiscal year
Equity share capital remained unchanged at Rs 448.05 lacs
Cash and cash equivalents increased to Rs 160.08 lacs from Rs 64.38 lacs

Outlook

While the company has shown impressive growth in profitability, investors should note that these are unaudited results. The sustainability of this growth trend and the company's ability to maintain profitability in the face of potential market challenges will be key factors to watch in the coming quarters.

Unjha Formulations Limited continues to operate in a single business segment. The company reported no pending investor complaints at the beginning or end of the quarter, indicating good investor relations management.

As the pharmaceutical sector remains crucial in the current global health context, Unjha Formulations' performance may be of interest to investors looking at mid-cap pharma companies in the Indian market.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.68%	-3.81%	+5.19%	+3.87%	-17.66%	+233.47%

Unjha Formulations Limited has announced the appointment of Mr. Siddharth Shah as its new Company Secretary and Compliance Officer, effective October 1, 2025. The decision was made during a board meeting held on the same date, as disclosed in a regulatory filing to the Bombay Stock Exchange (BSE).

Key Appointment Details

Item	Detail
Name	Mr. Siddharth Shah
Position	Company Secretary and Compliance Officer
Effective Date	October 1, 2025
Professional Membership	Associate Member of the Institute of Company Secretaries of India (ICSI)
Membership Number	A67232

Professional Background

Mr. Shah brings over five years of diverse professional experience to his new role at Unjha Formulations. His expertise spans several critical areas:

Compliance
Insolvency and Bankruptcy
Finance
Taxation
Corporate Laws
Valuation
Audit
Secretarial Compliances
Due Diligence

Throughout his career, Mr. Shah has collaborated with Resolution Professionals, Liquidators, and Registered Valuers under the Insolvency and Bankruptcy Code (IBC), 2016. This experience has equipped him with a comprehensive understanding of complex corporate matters and the ability to provide both legal and financial solutions.

Appointment Process

The appointment of Mr. Siddharth Shah was made in accordance with:

Section 203 of the Companies Act, 2013 and its associated rules
Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Corporate Governance

This appointment underscores Unjha Formulations' commitment to maintaining strong corporate governance practices and ensuring compliance with regulatory requirements. As the Company Secretary and Compliance Officer, Mr. Shah will play a crucial role in overseeing the company's adherence to various statutory and regulatory obligations.

The board meeting that approved this appointment commenced at 3:30 PM and concluded at 4:00 PM on October 1, 2025.

Unjha Formulations Limited, headquartered in Sidhpur, North Gujarat, continues to strengthen its management team to support its business operations and maintain transparency with its stakeholders.